<ENAMEX TYPE="PERSON">Johnson Johnson</ENAMEX> reported a 10 rise in third quarter net income on a 12 sales increase results that were driven particularly by new products including pharmaceuticals and the company s professional operations Net for the <ENAMEX TYPE="ORGANIZATION">New Brunswick N J</ENAMEX> maker of health care products climbed to 265 million or 80 cents a share from 240 million or 71 cents a share in the year earlier period Sales rose to 2 45 billion from 2 2 billion The year ago per share earnings are adjusted to reflect a 2 for 1 stock split last May In a statement <ENAMEX TYPE="PERSON">Ralph S Larsen</ENAMEX> chairman and chief executive officer said the company was pleased with its third quarter sales performance especially in light of the extremely competitive environment in domestic consumer markets and the negative impact of unfavorable exchange rates this quarter <ENAMEX TYPE="PERSON">David J Lothson</ENAMEX> an industry analyst for <ENAMEX TYPE="ORGANIZATION">Painewebber Group Inc</ENAMEX> said <ENAMEX TYPE="PERSON">Johnson Johnson</ENAMEX> s results slightly exceeded his expectations for the third quarter In <ENAMEX TYPE="ORGANIZATION">New York Stock Exchange</ENAMEX> composite trading yesterday <ENAMEX TYPE="PERSON">Johnson Johnson</ENAMEX> shares fell 37 5 cents to 54 625 <ENAMEX TYPE="PERSON">Mr Larsen</ENAMEX> noted substantial sales growth for the recently introduced Acuvue disposable contact lens and <ENAMEX TYPE="PERSON">Hismanal</ENAMEX> a once a day antihistamine <ENAMEX TYPE="ORGANIZATION">Eprex</ENAMEX> used by dialysis patients who are anemic and Prepulsid a gastro intestinal drug did well overseas he said Despite health care cost controls and programs to hold down inventory the professional division which makes products including sutures and surgical stapling equipment achieved solid growth <ENAMEX TYPE="PERSON">Johnson Johnson</ENAMEX> said But domestic consumer sales slipped 1 2 for the quarter to 490 million from 496 million The company cited softness in the retail health and beauty aids category as well as the intense competition in the company s sanitary protection product line Overseas sales were stronger principally because of a rebound in <ENAMEX TYPE="LOCATION">Brazil</ENAMEX> where economic turmoil had hurt year earlier results <ENAMEX TYPE="PERSON">Johnson Johnson</ENAMEX> said <ENAMEX TYPE="PERSON">Mr Lothson</ENAMEX> of <ENAMEX TYPE="ORGANIZATION">Painewebber</ENAMEX> said the company s sales pace has been picking up largely because the effect of unfavorable exchange rates has been easing a pattern continuing this quarter He cautioned however that a tough tax rate comparison may slow the company s earnings growth for the current quarter For last year s fourth quarter the company s tax rate was less than 20 he said While the third period contained no major surprises <ENAMEX TYPE="PERSON">Mr Lothson</ENAMEX> said the results show how sensitive the multinationals can be to developments in a single country such as <ENAMEX TYPE="LOCATION">Brazil</ENAMEX> He also questioned whether recent gains in that country can be sustained <ENAMEX TYPE="PERSON">CO BBC CG TELV WGP</ENAMEX> The following issues were recently filed with the Securities and <ENAMEX TYPE="ORGANIZATION">Exchange Commission Bergen Brunswig Corp</ENAMEX> proposed offering of liquid yield option notes via <ENAMEX TYPE="ORGANIZATION">Merrill Lynch Capital Markets Columbia Gas System Inc</ENAMEX> shelf offering of up to 200 million of debentures <ENAMEX TYPE="ORGANIZATION">Laserscope</ENAMEX> initial offering of 1 656 870 common shares of which 1 455 000 shares are to be sold by the company and 201 870 by holders via <ENAMEX TYPE="PERSON">Alex Brown Sons Inc</ENAMEX> and <ENAMEX TYPE="ORGANIZATION">Volpe Covington Welty Televideo Systems Inc</ENAMEX> proposed offering of 1 853 735 common shares to be sold by holders <ENAMEX TYPE="LOCATION">Western Gas System Inc</ENAMEX> initial offering of 3 250 000 common shares of which 3 040 000 shares will be sold by the company and 210 000 by a holder via <ENAMEX TYPE="PERSON">Prudential Bache Capital Funding Smith Barney Harris Upham Co</ENAMEX> and Hanifen Imhoff <ENAMEX TYPE='untagged'>Inc</ENAMEX>